Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 5
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean camilla m andersson[Author] (4 results)?
Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program.
Andersen CF, Larsen JH, Jensen J, Omar M, Nouhravesh N, Kistorp C, Tuxen C, Gustafsson F, Knop FK, Forman JL, Davidovski FS, Jensen LT, Højlund K, Køber L, Antonsen L, Poulsen MK, Schou M, Møller JE. Andersen CF, et al. Am Heart J. 2024 May;271:84-96. doi: 10.1016/j.ahj.2024.02.005. Epub 2024 Feb 15. Am Heart J. 2024. PMID: 38365073 Free article.
The effect of empagliflozin on contractile reserve in heart failure: Prespecified sub-study of a randomized, double-blind, and placebo-controlled trial.
Jensen J, Omar M, Ali M, Frederiksen PH, Kistorp C, Tuxen C, Andersen CF, Larsen JH, Ersbøll MK, Køber L, Gustafsson F, Faber J, Forman JL, Møller JE, Schou M. Jensen J, et al. Among authors: andersen cf. Am Heart J. 2022 Aug;250:57-65. doi: 10.1016/j.ahj.2022.04.008. Epub 2022 May 2. Am Heart J. 2022. PMID: 35513022 Free article. Clinical Trial.
The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker).
Omar M, Jensen J, Kistorp C, Højlund K, Videbæk L, Tuxen C, Larsen JH, Andersen CF, Gustafsson F, Køber L, Schou M, Møller JE. Omar M, et al. Among authors: andersen cf. Cardiovasc Diabetol. 2022 Feb 27;21(1):34. doi: 10.1186/s12933-022-01463-2. Cardiovasc Diabetol. 2022. PMID: 35219331 Free PMC article. Clinical Trial.
Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trial.
Larsen JH, Omar M, Jensen J, Andersen CF, Kistrup CM, Poulsen MK, Videbæk L, Gustafsson F, Køber L, Schou M, Møller JE. Larsen JH, et al. Am Heart J Plus. 2023 Feb 3;26:100264. doi: 10.1016/j.ahjo.2023.100264. eCollection 2023 Feb. Am Heart J Plus. 2023. PMID: 38510180 Free PMC article.
12 results